Stage III Non-small Cell Lung Cancer Management in England

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 48.8K citations

Prognostic Assessment, Longitudinal Studies, Prognostic Comorbidity +11

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 5.9K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Peter Goldstraw, Kari Chansky, John Crowley et al. · Journal of Thoracic Oncology · 2016 · 4.5K citations · Full text

Advanced Lung Disease, Cancer Detection, Medicine +8

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.4K citations · Full text

Treatment of Stage I and II Non-small Cell Lung Cancer

John A. Howington, Matthew G. Blum, Andrew C. Chang et al. · CHEST Journal · 2013 · 1.4K citations

Medicine, Pathology, Bronchial Neoplasm +5